BWX Technologies stock hits 52-week low at 156.95 USD By Investing.com
BWX Technologies (BWXT) stock has dropped to a 52-week low of $156.95, reflecting a significant decline over recent months. Despite its stock being considered overvalued by InvestingPro, the company reported strong Q2 2026 adjusted earnings and an 18% increase in sales, driven by growth in its commercial nuclear segment. BWXT also raised its full-year free cash flow guidance and increased its backlog, suggesting a positive outlook supported by demand in nuclear power and defense.
BWXT Names Suzanne Maddux Operations SVP to Support Nuclear Growth
BWX Technologies Inc. has appointed Suzanne Maddux as Senior Vice President of Operations, a new executive position aimed at strengthening manufacturing, supply chain, and operational coordination. Maddux will report to BWXT President and CEO Rex Geveden and will oversee Environmental Health and Safety, Security, Operational Excellence, and Supply Chain, while also providing oversight for manufacturing operations, engineering, and quality. This role is crucial for improving coordination between the company's Government Operations and Commercial Operations organizations to support its growing backlog and expand production capacity in nuclear national security and commercial nuclear power markets.
Denali Advisors LLC Purchases Shares of 7,114 BWX Technologies, Inc. $BWXT
Denali Advisors LLC has acquired 7,114 shares of BWX Technologies, Inc. (NYSE:BWXT) worth approximately $1.385 million during the second quarter. Several other institutional investors also established new positions in the company, bringing the total institutional ownership to 94.39%. BWXT reported strong quarterly earnings, beating EPS estimates and showing significant revenue growth, and maintained its fiscal 2026 EPS guidance.
BWX Technologies (BWXT) Wins ANEEL Fuel Review Role, Is It Still 32% Below Fair Value?
BWX Technologies (BWXT) recently secured a role for its Kinectrics division to review the ANEEL fuel qualification program, sparking renewed interest in the company. Despite recent short-term share price declines, the company has a strong 5-year total shareholder return of 197.56% and a record $6 billion backlog. While one valuation narrative suggests BWXT is 32% undervalued with a fair value of $238.79, its current P/E ratio of 41.9x is higher than industry averages, prompting investors to consider both perspectives.
BlackRock Inc. Takes Position in BWX Technologies, Inc. $BWXT
BlackRock Inc. has acquired a new position in BWX Technologies, Inc. (NYSE:BWXT) during the second quarter, purchasing over 12.1 million shares valued at approximately $2.36 billion, representing about 13.23% of the company. Other institutional investors also increased their holdings in BWXT, while the company's CEO sold 10,000 shares. BWX Technologies reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend.
BWX Technologies (BWXT) Wins ANEEL Fuel Review Role, Is It Still 32% Below Fair Value?
BWX Technologies (BWXT) has gained attention after its Kinectrics division was chosen to review the ANEEL fuel qualification program. Despite recent short-term share price declines, the company's 5-year total shareholder return remains strong. The article discusses the valuation of BWXT, noting a narrative that places its fair value 32% above its current price due to a large backlog and growth prospects, although its P/E ratio is higher than industry averages.
BWX Technologies (BWXT) Stock May Be Fully Priced Despite Nuclear Growth Hopes
BWX Technologies (BWXT) has shown strong returns over the past five years, but current analyses suggest its stock may be overvalued, trading above its estimated intrinsic value. Despite the company's involvement in promising nuclear fuel and enrichment projects, valuation checks indicate that these growth hopes might already be priced into the stock. Both Discounted Cash Flow and P/E ratio analyses suggest BWXT is currently overvalued, leading to a debate between bull and bear cases regarding its future potential and execution risks.
13,453 Shares in BWX Technologies, Inc. $BWXT Acquired by M.D. Sass LLC
M.D. Sass LLC has acquired 13,453 shares of BWX Technologies (NYSE:BWXT) valued at approximately $2.6 million during the second quarter of 2026. This acquisition contributes to the 94.39% institutional ownership of the company. BWX Technologies reported strong Q2 earnings, surpassing analyst estimates with EPS of $1.07 and an 18% year-over-year revenue increase, while maintaining its fiscal 2026 EPS guidance.
Compass Wealth Management LLC Takes Position in BWX Technologies, Inc. $BWXT
Compass Wealth Management LLC acquired 15,840 shares of BWX Technologies, Inc. ($BWXT) valued at approximately $3.08 million during the second quarter. Institutional investors collectively own 94.39% of the company, which reported quarterly EPS of $1.07, exceeding estimates, and reaffirmed its fiscal 2026 EPS guidance. Analysts maintain a "Moderate Buy" consensus for BWX Technologies with an average price target of $227.20.
Analysts Are Neutral on Top Industrial Goods Stocks: BWX Technologies (BWXT), Transurban Group (TRAUF)
Analysts have issued neutral ratings for industrial goods stocks BWX Technologies (BWXT) and Transurban Group (TRAUF), indicating neither a bullish nor bearish outlook. Truist Financial maintained a Hold rating on BWX Technologies with a $202.00 price target, while RBC Capital maintained a Hold rating on Transurban Group with an A$14.25 price target. Despite the neutral ratings, BWX Technologies has a Strong Buy consensus with a 36.0% upside, and Transurban Group has a Moderate Sell consensus with a -4.2% downside.
CCTE Engages Kinectrics to Independently Review ANEEL Fuel Qualification Program
Clean Core Thorium Energy (CCTE) has partnered with Kinectrics Inc. for an independent technical review of its ANEEL fuel qualification program, a critical step towards commercial reactor demonstration. This collaboration, alongside existing partnerships with BWXT Canada and Canadian Nuclear Laboratories, aims to validate the fuel's design, manufacturing, and safety, leveraging Canada's nuclear supply chain. The initiative builds on CCTE's recent technical milestones, including successful irradiation testing and peer-reviewed engineering assessments, paving the way for advanced thorium-based fuel deployment in existing reactors.
Here's How Much $100 Invested In BWX Technologies 10 Years Ago Would Be Worth Today
Over the past decade, BWX Technologies (NYSE: BWXT) has shown strong performance, outperforming the market with an annualized return of 15.87%. An investment of $100 in BWXT stock 10 years ago would now be worth $437.94, highlighting the significant impact of compounded returns on cash growth. The company currently holds a market capitalization of $15.71 billion.
Nuclear Earnings Season: A Tale of Two Markets – Profitable Operators vs. Speculative Start-Ups
The latest nuclear earnings season reveals a stark division: profitable operators and manufacturers are delivering strong results, while speculative early-stage developers are burning cash and missing forecasts. Despite this, the most speculative stocks are experiencing sharper rallies, indicating investor focus on long-term nuclear demand over current financial performance. This creates a dichotomy where steady earners are overlooked in favor of high-growth potential, emphasizing the diverse risk profiles within the nuclear energy sector.
Oppenheimer Asset Management Inc. Acquires Shares of 6,334 BWX Technologies, Inc. $BWXT
Oppenheimer Asset Management Inc. has acquired 6,334 shares of BWX Technologies, Inc. (NYSE:BWXT) worth approximately $1.23 million, marking a new position for the firm. This comes as institutional investors collectively own 94.39% of the company, with several others increasing their holdings. BWX Technologies recently surpassed earnings expectations, reporting $1.07 EPS against $1.04 expected, and analysts maintain a "Moderate Buy" rating with an average price target of $227.20.
Chase Investment Counsel Corp Makes New Investment in BWX Technologies, Inc. $BWXT
Chase Investment Counsel Corp has acquired a new stake of 6,029 shares in BWX Technologies, valued at approximately $1.17 million. BWX Technologies reported strong quarterly earnings, beating estimates with $1.07 EPS and an 18% increase in revenue year-over-year, and reaffirmed its fiscal 2026 EPS guidance. Analysts maintain a "Moderate Buy" rating with a consensus price target of $227.20.
Current Analysis of Nuclear Sector: Revenue and Prospects
This article provides an analysis of the nuclear sector, highlighting strong revenue performance from established companies like Constellation Energy, BWX Technologies, and Cameco, driven by stable contracts and increased demand. It also points out the uncertain prospects for newcomers like NuScale Power, which is struggling with commercialization. The analysis underscores the significant growth potential within the sector for key players, supported by analyst forecasts and market recovery trends.
BWX Technologies, Inc. Declares Quarterly Dividend of $0.27 (NYSE:BWXT)
BWX Technologies, Inc. (NYSE:BWXT) has declared a quarterly dividend of $0.27 per share, payable on September 4, 2026, to shareholders of record on August 18, 2026. This dividend represents an annualized yield of 0.6% and is well-supported by the company's earnings, with a current payout ratio of 27.6% expected to decline to 20.6% next year. The company recently reported strong quarterly earnings, beating estimates with $1.07 EPS and an 18% year-over-year revenue increase to $901.62 million, and maintained its fiscal 2026 EPS guidance.
Pecaut & CO. Invests $1.54 Million in BWX Technologies, Inc. $BWXT
Pecaut & CO. has made a new investment of $1.54 million in BWX Technologies (NYSE: BWXT) during the second quarter, joining other institutional investors who collectively own 94.39% of the company. Despite some recent analyst downgrades, BWXT maintains a "Moderate Buy" consensus rating with an average price target of $227.20. The company reported strong quarterly earnings, surpassing expectations with $1.07 EPS and an 18% year-over-year revenue increase to $901.62 million, and also declared a quarterly dividend of $0.27 per share.
BWXT Maintained by Truist Securities -- Price Target Lowered to $202
Truist Securities has maintained a 'Hold' rating on BWX Technologies Inc (BWXT) but lowered its price target from $212.00 to $202.00. GuruFocus indicates BWXT is currently 12.7% overvalued with a GF Value™ of $153.13, despite having a strong GF Score™ of 92/100, driven by high profitability and growth. Insider activity shows net selling, and investors are advised to exercise caution due to the stock's overvaluation.
Here's How Much $1000 Invested In BWX Technologies 10 Years Ago Would Be Worth Today
BWX Technologies (NYSE: BWXT) has shown strong market outperformance over the last 10 years, with an annualized return of 15.91%. An initial investment of $1000 in BWXT stock a decade ago would now be worth $4,453.59. This highlights the significant impact of compounded returns on investment growth over time.
BWX Technologies president and CEO sells over $1.7m in shares
Rex D. Geveden, President and CEO of BWX Technologies (NASDAQ:BWXT), sold 10,000 shares of the company's common stock for over $1.7 million on August 12, 2026, pursuant to a Rule 10b5-1 trading plan. This insider sale occurs as BWXT stock is down 14% over the past six months and is considered overvalued by InvestingPro analysis, despite the company reporting better-than-expected adjusted earnings and raising its full-year free cash flow guidance.
Here's How Much $1000 Invested In BWX Technologies 10 Years Ago Would Be Worth Today
An investment of $1000 in BWX Technologies (NYSE: BWXT) 10 years ago would be worth $4,453.59 today, demonstrating an annualized return of 15.91%. This performance has outperformed the market by 2.37% annually. The article highlights the significant impact of compounded returns on investment growth over time.
BWX Technologies (NYSE:BWXT) CEO Rex Geveden Sells 10,000 Shares of Stock
BWX Technologies CEO Rex Geveden sold 10,000 shares of the company's stock for $1.725 million under a pre-arranged trading plan, reducing his holdings to 192,491 shares. The sale followed strong quarterly results, with adjusted EPS and revenue exceeding expectations, and the company reaffirmed its fiscal 2026 EPS guidance. Analysts maintain a "Moderate Buy" rating for BWXT, with an average price target of $228.20.
BWX Technologies president and CEO sells over $1.7m in shares
Rex D. Geveden, President and CEO of BWX Technologies (NASDAQ:BWXT), sold 10,000 shares of company stock for over $1.7 million on August 12, 2026, as part of a pre-arranged trading plan. This sale occurred while BWXT stock has declined by approximately 14% over the past six months and is considered overvalued according to InvestingPro. Despite recent Q2 2026 adjusted earnings beating estimates, revenue slightly missed expectations, though the company raised its full-year free cash flow guidance and reported a significant increase in its backlog.
BWX Technologies (BWXT) CEO Geveden sells 10,000 shares under Rule 10b5-1 plan
BWX Technologies (BWXT) CEO Rex D. Geveden sold a total of 10,000 shares of common stock on August 12, 2026, at weighted average prices between $170.65 and $174.24 per share. These sales were conducted under a pre-arranged Rule 10b5-1 trading plan that was adopted on August 11, 2025. Following these transactions, Geveden directly holds 192,491 shares of common stock.
Can BWX Technologies' Nuclear Medicine Expansion Boost Growth?
BWX Technologies (BWXT) is expanding its commercial nuclear portfolio into nuclear medicine and medical radioisotopes, driven by its acquisition of Kinectrics. This move allows BWXT to diversify its operations beyond traditional nuclear energy, leveraging increased demand for specialized medical applications. The company's earnings are projected to grow, and its stock is currently trading at a discount relative to its industry.
How Investors May Respond To BWX Technologies (BWXT) Raised 2026 Outlook And Nuclear Enrichment Push
BWX Technologies (BWXT) recently reported strong Q2 and H1 2026 results, raising its full-year 2026 revenue outlook to $3.80 billion and declaring a $0.27 quarterly dividend. The company is also accelerating its uranium centrifuge technology work with the National Nuclear Security Administration to support U.S. nuclear enrichment. While the raised guidance reinforces the company's existing narrative of stable growth driven by a record backlog and expanding nuclear work, investors should remain aware of the inherent risk associated with its heavy reliance on government contracts.
BWX Technologies (NYSE: BWXT) insider plans sale of 10,000 shares valued at $1.73M
An insider at BWX Technologies, Rex D. Geveden, plans to sell 10,000 shares of common stock valued at $1.73 million on or after August 12, 2026. These shares were acquired through RSU/PSU equity compensation on February 27, 2023. This planned sale follows a prior sale of 10,000 shares for $2.05 million within the last three months.
31,104 Shares in BWX Technologies, Inc. $BWXT Acquired by Insight Wealth Strategies LLC
Insight Wealth Strategies LLC recently acquired 31,104 shares of BWX Technologies, Inc. (BWXT) valued at approximately $5.95 million. This move is part of broader institutional interest, with hedge funds and institutional investors collectively owning 94.39% of the company. BWXT reported strong quarterly earnings, surpassing analyst expectations, and maintains a "Moderate Buy" consensus rating from analysts with an average price target significantly above its current trading price.
Tema ETFs LLC Acquires 25,368 Shares of BWX Technologies, Inc. $BWXT
Tema ETFs LLC significantly increased its stake in BWX Technologies (NYSE:BWXT) by 45.5% in the second quarter, adding 25,368 shares to reach a total of 81,179 shares valued at approximately $15.8 million. Institutional investors now hold 94.39% of BWXT's stock, reflecting strong institutional confidence. The company also reported strong financial results, exceeding EPS expectations and showing an 18% year-over-year revenue increase, alongside declaring a quarterly dividend.
How Investors May Respond To BWX Technologies (BWXT) Raised 2026 Outlook And Nuclear Enrichment Push
BWX Technologies, Inc. recently reported strong Q2 2026 results, raising its full-year revenue outlook to approximately US$3.80 billion and accelerating its work on uranium centrifuge technology with the National Nuclear Security Administration. This guidance update reinforces the company's existing investment narrative of demand for specialized nuclear components and services, primarily tied to U.S. defense programs, while highlighting its reliance on government contracts as a key risk. The company's narrative projects $4.7 billion revenue by 2029, suggesting a significant upside to its current price.
Renaissance Technologies LLC Buys New Stake in BWX Technologies, Inc. $BWXT
Renaissance Technologies LLC has acquired a new stake of 11,600 shares in BWX Technologies, Inc. (NYSE:BWXT) valued at approximately $2.37 million during the first quarter. BWX Technologies reported strong financial results with quarterly EPS of $1.07, surpassing estimates, and revenue up 18% year-over-year. Analysts maintain a "Moderate Buy" rating for the company with an average price target of $228.20.
How Investors May Respond To BWX Technologies (BWXT) Raised 2026 Outlook And Nuclear Enrichment Push
BWX Technologies reported strong Q2 and H1 2026 results, raising its full-year revenue outlook to $3.80 billion and declaring a quarterly dividend. The company is also advancing uranium centrifuge technology with the National Nuclear Security Administration, supporting a potential U.S. nuclear enrichment buildout. This strengthens BWXT's investment narrative, emphasizing demand for specialized nuclear components and services, though reliance on government contracts remains a key risk.
Nuclear Fuel Deals Frame the Future of Advanced Reactors
The article discusses the critical issue of nuclear fuel supply for advanced micro and small modular reactors, highlighting that many of these reactors require High-Assay Low-Enriched Uranium (HALEU) or TRISO fuel, which are currently in short supply. It details various fuel deals and partnerships, including Centrus Energy's agreement with X-energy, Curio's MOU with NuScale Power and Framatome for fuel recycling, Newcleo's regulatory engagement for a MOX fuel facility, CCTE's fuel supply agreement with BWXT Canada, and ORNL's fusion fuel deal with Type One Energy. The piece emphasizes the challenge of diverse fuel requirements across advanced reactor designs and the need for coordinated efforts between developers, fuel fabricators, and regulators to ensure timely fuel availability.
Enterprise value to EBITDA forward of BWX Technologies, Inc. – DUS:4BW
The article is a financial data page from TradingView for BWX Technologies, Inc. (DUS:4BW), focusing on its enterprise value to forward EBITDA. It appears to be a stub or placeholder, as no specific financial figures are present, only the category and general navigation elements of the TradingView platform.
The Technical Signals Behind (BWXT) That Institutions Follow
This article provides a technical analysis of Bwx Technologies Inc. (NASDAQ: BWXT), highlighting neutral near and mid-term readings but a positive long-term bias. It outlines three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles. The analysis also includes multi-timeframe signal analysis with support and resistance levels.
BWX Technologies, Inc. (NYSE:BWXT) Given Average Recommendation of "Moderate Buy" by Brokerages
BWX Technologies, Inc. (BWXT) has received an average "Moderate Buy" rating from fifteen brokerages, with an average 12-month price target of $228.20. The company recently exceeded quarterly earnings expectations with an EPS of $1.07 and revenue of $901.62 million, and guided for fiscal 2026 EPS of $4.70–$4.80. Despite recent insider share sales, institutional investors hold a significant 94.39% stake, and the company announced a quarterly dividend of $0.27 per share.
BWX Technologies (NYSE:BWXT) Downgraded by Wall Street Zen to Hold
Wall Street Zen has downgraded BWX Technologies (NYSE:BWXT) from "Buy" to "Hold" despite a broader analyst consensus of "Moderate Buy" with an average price target of $228.20. The company recently reported strong quarterly earnings, beating EPS estimates and seeing an 18% year-over-year revenue increase, while maintaining its fiscal 2026 EPS guidance. However, the stock opened significantly below its 12-month high, and both the CEO and CFO have recently sold shares.
Advance Auto Parts vs. BWX Technologies: Is an Auto Parts Retailer or a Nuclear Energy Pioneer the Better Buy in 2026?
This article compares Advance Auto Parts (AAP) and BWX Technologies (BWXT) as investment opportunities in 2026. While Advance Auto Parts is undergoing a restructuring to improve its operational efficiency in the competitive auto parts retail market, BWX Technologies benefits from stable government contracts and the growing demand for nuclear energy. The analysis concludes that BWX Technologies is the better long-term buy due to its position in a growing sector compared to Advance Auto Parts' efforts to revive its prospects in a highly competitive retail industry.
Pacer Advisors Inc. Sells 1,998,424 Shares of BWX Technologies, Inc. $BWXT
Pacer Advisors Inc. significantly reduced its stake in BWX Technologies, selling 1,998,424 shares and retaining 30,477 shares. Despite this, other institutional investors have recently increased their holdings, and institutions still own 94.39% of the company. BWX Technologies reported strong Q1 earnings, exceeding analyst expectations, and management reaffirmed its fiscal 2026 EPS guidance.
BWX Technologies (NYSE: BWXT) lifts Q2 sales 18% as backlog hits $8,398.1M
BWX Technologies reported an 18% year-over-year increase in Q2 2026 revenue to $901.6 million and a 21.8% rise in year-to-date revenue to $1.76 billion, driven by strong growth in Commercial Operations and recent acquisitions. The company's backlog reached $8,398.1 million, with 55% expected to be recognized by the end of 2027. BWXT also announced an agreement to sell its medical business to Nordic Capital for up to $800 million.
BWX Technologies (BWXT) Stock Price Lags Backlog Surge and Premium P E
BWX Technologies (BWXT) saw its stock price barely move despite a strong Q2 earnings report, including an 18% revenue increase, a 14% rise in net income, and a 40% jump in backlog to $8.4 billion. The article explores the bull case, highlighting the company's shift towards a broader nuclear growth platform and increased multi-year visibility, while also addressing bear arguments concerning valuation, government dependence, and potential margin pressures from commercial growth. Despite solid financial results, the stock's recent 20% decline over 90 days suggests investor concerns about execution complexity and concentration persist.
Rep. April McClain Delaney Buys Shares of BWX Technologies, Inc. (NYSE:BWXT)
Representative April McClain Delaney recently purchased between $15,001 and $50,000 worth of BWX Technologies (NYSE:BWXT) stock on July 24th, along with other stock transactions in late July. BWXT reported strong second-quarter results with adjusted EPS of $1.07 and an 18% revenue increase, leading management to raise its 2026 adjusted EPS and free cash flow guidance. The company also agreed to sell its medical business for up to $800 million to fund expansion in nuclear and naval propulsion.
Janus Henderson Group PLC Sells 77,120 Shares of BWX Technologies, Inc. $BWXT
Janus Henderson Group PLC reduced its stake in BWX Technologies (NYSE:BWXT) by 52.5% in the first quarter, selling 77,120 shares but still retaining 69,794 shares valued at $14.3 million. Despite this sale, institutional investors collectively own 94.39% of the company. BWX Technologies reported strong Q2 earnings, beating EPS estimates, and management raised its fiscal 2026 EPS outlook, supported by commercial nuclear growth and acquisitions, leading to a "Moderate Buy" consensus rating from analysts.
Rep. April McClain Delaney Purchases Shares of BWX Technologies, Inc. (NYSE:BWXT)
Representative April McClain Delaney recently purchased shares of BWX Technologies, Inc. (NYSE:BWXT) valued between $1,001 and $15,000 on July 27th. This purchase comes as BWXT reported strong second-quarter results, beating adjusted EPS estimates and seeing an 18% revenue increase year-over-year. The company also reaffirmed its 2026 EPS guidance and raised free-cash-flow guidance, while analysts maintain a "Moderate Buy" rating with an average price target of $228.20.
Should BWX Technologies’ Guidance Hike and Medical Exit Reshape BWXT’s Nuclear‑Focused Investment Case?
BWX Technologies reported strong Q2 2026 results, raising its full-year revenue guidance and declaring a dividend. The company also announced the sale of most of its medical business to focus on core nuclear markets. This strategic shift reinforces its investment case centered on long-term U.S. defense and nuclear power spending, while also increasing its exposure to government and commercial nuclear catalysts.
BWX Technologies, Inc. Stock 12‑Month Price Target Cut to $235.77, Implies 36% Upside
The average 12-month price target for BWX Technologies, Inc. stock has been reduced from $239 to $235.77 by 13 analysts, with individual forecasts ranging from $190 to $290. This updated target suggests a potential upside of approximately 36% based on the August 3rd closing price. Despite the slight target cut, the consensus rating from 17 analysts remains a "Buy."
BWXT Q2 Earnings Call Centers on Higher Outlook and Nuclear Focus
BWX Technologies, Inc. (BWXT) reported strong Q2 2026 earnings, surpassing analyst estimates for both earnings per share and revenue. The company raised its full-year outlook, emphasizing a sharpened strategic focus on core nuclear markets, expanding nuclear manufacturing capacity, and benefits from the sale of its medical and related stable-isotope businesses and the acquisition of Precision Components Group. CEO Rex Geveden highlighted the company's commitment to predictable government and aftermarket bases while pursuing growth in higher-potential nuclear sectors.
BWXT Q2 Earnings Call Centers on Higher Outlook and Nuclear Focus
BWX Technologies (BWXT) reported strong Q2 2026 results, exceeding revenue and EPS estimates, and subsequently raised its full-year 2026 outlook. The company's strategic focus is now narrowed to core nuclear markets following the sale of its medical and stable-isotope businesses, while also expanding its commercial nuclear manufacturing capacity. CEO Rex Geveden and CFO Michael Fitzgerald detailed plans for investment, acquisitions, and a more predictable government and aftermarket business.
Maryland Rep. April McClain Delaney Bought Up to $900K Worth of BWX Technologies Stock
Maryland Representative April McClain Delaney recently purchased BWX Technologies stock valued between $200,032 and $900,000, with the transaction occurring on July 24, 2026. Over the past three years, Delaney has executed 408 trades totaling over $982,000. Congressional transactions are required to be disclosed under the STOCK Act, which prohibits members of Congress from using non-public information for personal financial gain.
